The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.
The ATHENA Study, officially titled ‘ItAlian, Multicenter, Observational, Prospective sTudy to Evaluate the acHievement of Clinical rEmission and immuNomodulation in Severe Eosinophilic Asthma ...
The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
The Food and Drug Administration has announced that it is cracking down on direct-to-consumer (DTC) prescription drug advertising. It sent out around 100 letters to drug companies warning that many ...
The Food and Drug Administration has announced that it is cracking down on direct-to-consumer (DTC) prescription drug advertising. It sent out around 100 letters to drug companies warning that many ...
In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...
For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...
A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon following the discovery of a potential new therapeutic target by scientists at the ...
From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Three Pennsylvania cities were recently ranked among the worst in the country for ...
SYRACUSE, N.Y. — As the third week of September unfolds, doctors are alerting asthma sufferers to brace for what is known as "Asthma Peak Week," a period marked by worsening symptoms and increased ...
Please provide your email address to receive an email when new articles are posted on . Researchers reported no link between menopause and lifetime, active or severe asthma among women who never used ...
Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results